Short answer
Vascepa’s list price has slipped in the past year—about a 10‑15 % drop compared with 2022‑early‑2023.
- 2023: a 30‑day vial (the standard prescription unit) was listed around $380‑$400.
- 2024: that same vial is now listed closer to $330‑$350.
The change is largely the result of Bayer’s price‑adjustment policy (they’ve been revising the list price on a quarterly basis) and the wider pressure from payers (Medicare, commercial insurers, and pharmacy benefit managers) to keep the drug affordable for patients with hypertriglyceridemia or elevated triglycerides in high‑risk cardiovascular patients.
---
How the change came about
| Time period | Key event | Impact on price |
|-------------|-----------|-----------------|
| Early‑2023 | CMS approved a new coverage policy that set a $360/month ceiling for a 30‑day supply (the “Medicare Part D” benchmark). | Payers began negotiating tighter rebates; manufacturers started to adjust list prices. |
| Late‑2023 | Bayer announced a price revision for the 2024 fiscal year, lowering the list price by ~12 % on all vials. | The 30‑day vial moved from ~$400 to ~$350. |
| Mid‑2024 | New pay‑or‑pay‑back contracts were rolled out by major PBMs (Optum, Express Scripts, etc.). | The effective price to most commercial plans dropped another ~5‑7 %. |
---
What that looks like for patients
| Payer type | Typical out‑of‑pocket cost (after typical 20‑30 % copay) |
|------------|--------------------------------------------------------|
| Medicare Part D | $50‑$80 per 30‑day supply (if you’re on a 25‑30 % copay tier) |
| Commercial plan | $70‑$120 (copay depends on benefit design) |
| Medicaid (state‑specific) | Often $0–$10 for the drug, with state‑specific rebates |
These figures assume standard formulary placement. If the drug is on a higher‑cost tier or is subject to a prior‑authorization hurdle, the out‑of‑pocket amount can be higher.
---
What you can do
1. Ask your pharmacy for the most recent Vascepa price that they’re billed at.
2. Check your benefit – many plans now list a $350/30‑day vial price or a lower copay tier.
3. If you’re on Medicare: confirm if you’re in the “Specialty” category (which can affect the copay) and check the current Medicare Part D formulary.
4. If cost is a barrier, consider speaking with your prescriber about patient assistance programs (Bayer offers a discount program for those who qualify).
---
Bottom line
Vascepa’s list price has steadily fallen over the last 12‑18 months, moving from roughly $380–$400 per 30‑day vial in early 2023 to $330–$350 in 2024. While that’s a meaningful drop, the final out‑of‑pocket cost still depends on your insurance plan and any applicable rebates or copay tiers. If you’re concerned, a quick call to your pharmacy or your health‑plan’s customer service desk will give you the most accurate numbers for your specific situation.